1. Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes
- Author
-
Jae-Hoon Song, Kyong Ran Peck, Norazah Ahmad, Revathy Arushothy, Kwan Soo Ko, Si Huei Tan, Hui Wang, Jin Yang Baek, Doo Ryeon Chung, David C. Lye, Visanu Thamlikitkul, Celia C. Carlos, Cheol-In Kang, and So Hyun Kim
- Subjects
Adult ,Serotype ,China ,medicine.medical_specialty ,Philippines ,030231 tropical medicine ,Microbial Sensitivity Tests ,Drug resistance ,Serogroup ,medicine.disease_cause ,Pneumococcal Infections ,Pneumococcal conjugate vaccine ,Pneumococcal Vaccines ,03 medical and health sciences ,0302 clinical medicine ,Antibiotic resistance ,Drug Resistance, Bacterial ,Republic of Korea ,Epidemiology ,Streptococcus pneumoniae ,medicine ,Humans ,Prospective Studies ,030212 general & internal medicine ,Serotyping ,Singapore ,General Veterinary ,General Immunology and Microbiology ,business.industry ,Malaysia ,Public Health, Environmental and Occupational Health ,Infant ,Middle Aged ,Thailand ,medicine.disease ,Virology ,Anti-Bacterial Agents ,Multiple drug resistance ,Pneumonia ,Infectious Diseases ,Pharmaceutical Preparations ,Molecular Medicine ,Macrolides ,business ,medicine.drug - Abstract
This study was performed to investigate the serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in Asian countries. A prospective surveillance study on S. pneumoniae collected from adult patients (≥50 years old) with invasive pneumococcal disease or community-acquired pneumonia was performed at 66 hospitals in Asian countries (Korea, China, Malaysia, Singapore, the Philippines, and Thailand) in 2012-2017. Serotyping and antimicrobial susceptibility tests of 850 pneumococcal isolates were performed. The proportions of isolates with serotypes covered by 13-valent pneumococcal conjugate vaccine (PCV13) were 37.0% in Korea, 53.4% in China, 77.2% in Malaysia, 35.9% in the Philippines, 68.7% in Singapore, and 60.2% in Thailand. Major serotypes were 19F (10.4%), 19A (10.1%), and 3 (8.5%) in 2012-2017, with different serotype distributions in each country. Macrolide resistance in pneumococci was high (66.8%) and prevalence of multidrug resistance (MDR) also remained high (50.8%). MDR non-PCV13 serotypes such as 11A, 15A, 35B, and 23A have emerged in Asian countries. This study showed the persistent prevalence of 19F and 19A with a noteworthy increase of certain non-PCV13 serotypes in Asian countries. High prevalence of macrolide resistance and MDR was also found in pneumococcal isolates. These data emphasize the need for continued surveillance of pneumococcal epidemiology in Asia in the post-pneumococcal vaccine era.
- Published
- 2020
- Full Text
- View/download PDF